Cellectar biosciences reports complete central nervous system (cns) clearance in relapsed/refractory waldenstrom's macroglobulinemia patient

Iopofosine i 131 active in treating malignancies in the brain; confirmed response in cns lymphoma provides additional validation for continued development of iopofosine in multiple cns malignancies iopofosine i 131 active in treating malignancies in the brain; confirmed response in cns lymphoma provides additional validation for continued development of iopofosine in multiple cns malignancies
CLRB Ratings Summary
CLRB Quant Ranking